Back to top

L'institut Servier. Supporting research. Fostering vocations

Internalising symptoms linked to migraine in children
The findings of a systematic review and meta-analysis support an association between anxiety and depression symptoms and migraine in children and adolescents.
FIREFISH 2-year data show continued benefit of risdiplam for type 1 SMA
The 24-month results from part 2 of the open-label FIREFISH trial suggest that prolonged treatment with risdiplam is associated with continued improvements in motor function and development in infants with type 1 spinal muscular atrophy (SMA).
Kawasaki disease incidence during COVID-19 sheds light on pathogenesis
Data from a nationwide hospital survey show a marked decrease in the incidence of Kawasaki disease in Japan in 2020 compared with the previous year, with differences in patterns of reduction between children younger than 12 months and those aged 24 months or more.

Pages

Annual Scientific Sessions

2021 EDITION

Heterogeneity in diabetes and beta cells

Neurodegeneration: Mechanisms and therapeutic targets

This year over two days in November, L'Institut Servier organizes Scientific Days in Paris, which includes 2 Scientific Colloquiums on different themes.

Consult the previous colloquia publications
cover video
2021 COLLOQUIUM
November 17th, 2021
HETEROGENEITY IN DIABETES
AND BETA CELLS
Chaired by: Professors Christian BOITARD and Raphaël SCHARFMANN

Learn more
2021 colloquium
November 18th, 2021
Neurodegeneration: Mechanisms and therapeutic targets
Chaired by: Professors Didier Leys and Jean-Louis Mas

Learn more
L'Institut SERVIER is a non-profit association under French law.
Its aim is to promote all forms of scientific and medical knowledge thus contributing to medical progress,
patient wellbeing and physician expectations.

Colloquia
organized

21

Laureate
Symposium

5

Grants
allocated

274

Pasteur-Weizmann-
Servier Prize
award

7